Mer­ck pulls Keytru­da in SCLC af­ter ac­cel­er­at­ed nod. Is the FDA get­ting tough on drug­mak­ers that don't hit their marks?

In what could be an ear­ly shot in the bat­tle against drug­mak­ers that whiff on con­fir­ma­to­ry stud­ies to sup­port ac­cel­er­at­ed ap­provals, the FDA or­dered Bris­tol …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER